Clarithromycin inhibits fibroblast migration

Respiratory Medicine

Volumn 102, Issue 12, 2008, Pages 1769-1776

  Kohyama, Tadashi ^a   Yamauchi, Yasuhiro ^a   Takizawa, Hajime ^b   Itakura, Susumu ^a   Kamitani, Sumiko ^a   Kato, Jun ^a   Nagase, Takahide ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

Clarithromycin; Fibroblast; Macrolide; Migration

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CLARITHROMYCIN; FIBRONECTIN; KT 5720; MINOCYCLINE; THROMBOXANE A2;

ANTIBACTERIAL ACTIVITY; ARTICLE; CELL MIGRATION; CYTOTOXICITY; DRUG BLOOD LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; FETUS LUNG; FIBROBLAST; IN VITRO STUDY; LUNG MODEL; MIGRATION INHIBITION; NONHUMAN; PRIORITY JOURNAL; TISSUE CULTURE; WOUND HEALING;

ANTI-BACTERIAL AGENTS; CELL SURVIVAL; CELLS, CULTURED; CHEMOTAXIS; CLARITHROMYCIN; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; FIBRONECTINS; GELS; HUMANS; LUNG;

EID: 55649104742     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.06.020     Document Type: Article

References (42)

1. Rennard S.I., Jaurand M.C., Bignon J., Kawanami O., Ferrans VJ., Davidson J., et al. Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung. Am Rev Respir Dis 130 (1984) 267-274
2. Kudoh S., Azuma A., Yamamoto M., Izumi T., and Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157 (1998) 1829-1832
3. Pukhalsky A.L., Shmarina G.V., Kapranov N.I., Kokarovtseva S.N., Pukhalskaya D., and Kashirskaja N.J. Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease. Mediators Inflamm 13 (2004) 111-117
4. Takizawa H., Desaki M., Ohtoshi T., Kikutani T., Okazaki H., Sato M., et al. Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action. Biochem Biophys Res Commun 210 (1995) 781-786
5. Takizawa H., Desaki M., Ohtoshi T., Kawasaki S., Kohyama T., Sato M., et al. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. Am J Respir Crit Care Med 156 (1997) 266-271
6. Kohyama T., Takizawa H., Kawasaki S., Akiyama N., Sato M., and Ito K. Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. Antimicrob Agents Chemother 43 (1999) 907-911
7. Sasaki M., Ito T., Kashima M., Fukui S., Izumiyama N., Watanabe A., et al. Erythromycin and clarithromycin modulation of growth factor-induced expression of heparanase mRNA on human lung cancer cells in vitro. Mediators Inflamm 10 (2001) 259-267
8. Mikasa K., Sawaki M., Kita E., Hamada K., Teramoto S., Sakamoto M., et al. Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin. Chemotherapy 43 (1997) 288-296
9. Sakamoto M., Mikasa K., Majima T., Hamada K., Konishi M., Maeda K., et al. Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer. Chemotherapy 47 (2001) 444-451
10. Li Y., Azuma A., Takahashi S., Usuki J., Matsuda K., Aoyama A., et al. Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice. Chest 122 (2002) 2137-2145
11. Watanabe A., Anzai Y., Niitsuma K., Saito M., Yanase K., and Nakamura M. Penetration of minocycline hydrochloride into lung tissue and sputum. Chemotherapy 47 (2001) 1-9
12. Morris D.L., De Souza A., Jones J.A., and Morgan W.E. High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose. Eur J Clin Microbiol Infect Dis 10 (1991) 859-861
13. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 115 (1962) 453-466
14. Bell E., Ivarsson B., and Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci U S A 76 (1979) 1274-1278
15. Mio T., Adachi Y., Romberger D.J., Ertl R.F., and Rennard S.I. Regulation of fibroblast proliferation in three dimensional collagen gel matrix. In Vitro Cell Dev Biol 32 (1996) 427-433
16. Elsdale T., and Bard J. Collagen substrata for studies on cell behavior. J Cell Biol 54 (1972) 626-637
17. Kohyama T., Ertl R.F., Valenti V., Spurzem J., Kawamoto M., Nakamura Y., et al. Prostaglandin E(2) inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol 281 (2001) L1257-L1263
18. Kohyama T., Liu X.D., Wen F.Q., Kim H.J., Takizawa H., and Rennard S.I. Prostaglandin D2 inhibits fibroblast migration. Eur Respir J 19 (2002) 684-689
19. Hunninghake W.C., Garret K.C., Richerson H.B., Fantone JC., Ward PA., Rennard SI., et al. Pathogenesis of the granulomatous lung disease (state of art). Am Rev Respir Dis 130 (1984) 476-496
20. Panos R.J., Mortenson R.L., Niccoli S.A., and King Jr. T.E. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med 88 (1990) 396-404
21. King Jr. T.E., Schwarz M.I., Brown K., Tooze JA., Colby TV., Waldron Jr. JA., et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 164 (2001) 1025-1032
22. Adachi Y., Mio T., Takigawa K., Striz I., Romberger DJ., Spurzem JR., et al. Fibronectin production by cultured human lung fibroblasts in three-dimensional collagen gel culture. In Vitro Cell Dev Biol Anim 34 (1998) 203-210
23. Grinnell F., Billingham R.E., and Burgess L. Distribution of fibronectin during wound healing in vivo. J Invest Dermatol 76 (1981) 181-189
24. Gauss-Muller V., Kleinman H.K., Martin G.R., and Schiffmann E. Role of attachment factors and attractants in fibroblast chemotaxis. J Lab Clin Med 96 (1980) 1071-1080
25. Postlethwaite A.E., Keski-Oja J., Balian G., and Kang A.H. Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med 153 (1981) 494-499
26. Doillon C.J., and Silver F.H. Collagen-based wound dressing: effects of hyaluronic acid and fibronectin on wound healing. Biomaterials 7 (1986) 3-8
27. Jarstrand C., Ahlgren T., and Berghem L. Fibronectin increases the motility, phagocytosis and NBT (nitroblue tetrazolium)-reduction of granulocytes. J Clin Lab Immunol 8 (1982) 59-63
28. Grinnell F. Fibronectin and wound healing. J Cell Biochem 26 (1984) 107-116
29. Hynes R.O., Ali I.U., Destree A.T., Mautner V., Perkins ME., Senger DR., et al. A large glycoprotein lost from the surfaces of transformed cells. Ann N Y Acad Sci 312 (1978) 317-342
30. Rennard S.I., Chen Y.F., Robbins R.A., Gadek J.E., and Crystal R.G. Fibronectin mediates cell attachment to C1q: a mechanism for the localization of fibrosis in inflammatory disease. Clin Exp Immunol 54 (1983) 239-247
31. Ogletree M.L. Overview of physiological and pathophysiological effects of thromboxane A2. Fed Proc 46 (1987) 133-138
32. Mene P., Abboud H.E., and Dunn M.J. Regulation of human mesangial cell growth in culture by thromboxane A2 and prostacyclin. Kidney Int 38 (1990) 232-239
33. Studer R.K., Craven P.A., and DeRubertis F.R. Thromboxane stimulation of mesangial cell fibronectin synthesis is signalled by protein kinase C and modulated by cGMP. Kidney Int 46 (1994) 1074-1082
34. Kohyama T., Liu X., Wen F.Q., Kim H.J., Takizawa H., and Rennard S.I. Potentiation of human lung fibroblast chemotaxis by the thromboxane A(2) analog U-46619. J Lab Clin Med 139 (2002) 43-49
35. Kohyama T., Wyatt T.A., Liu X., Wen FQ., Kobayashi T., Fang Q., et al. PGD2 modulates fibroblast-mediated native collagen gel contraction. Am J Respir Cell Mol Biol 27 (2002) 375-381
36. Kohyama T., Liu X., Wen F.Q., Zhu YK., Wang H., Kim HJ., et al. PDE4 inhibitors attenuate fibroblast chemotaxis and contraction of native collagen gels. Am J Respir Cell Mol Biol 26 (2002) 694-701
37. Kohyama T., Liu X., Kim H.J., Kobayashi T., Ertl RF., Wen FQ., et al. Prostacyclin analogs inhibit fibroblast migration. Am J Physiol Lung Cell Mol Physiol 283 (2002) L428-L432
38. Heuertz R.M., Tricomi S.M., Ezekiel U.R., and Webster R.O. C-reactive protein inhibits chemotactic peptide-induced p38 mitogen-activated protein kinase activity and human neutrophil movement. J Biol Chem 274 (1999) 17968-17974
39. Azuma M., Nishioka Y., Aono Y., Inayama M., Makino H., Kishi J., et al. Role of alpha1-acid glycoprotein in therapeutic antifibrotic effects of imatinib with macrolides in mice. Am J Respir Crit Care Med 176 (2007) 1243-1250
40. Kawashima M., yatsunami J., Fukuno Y., Nagata M., Tominaga M., and Hayashi S. Inhibitory effects of 14-membered ring macrolide antibiotics on bleomycin-induced acute lung injury. Lung 180 (2002) 73-89
41. Hoshino M., Nakamura Y., Sim J., Shimojo J., and Isogai S. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 102 (1998) 783-788
42. Saetta M., and Turato G. Airway pathology in asthma. Eur Respir J Suppl 34 (2001) 18s-23s